Chordate Medical Holding AB (publ) (CMH.ST)
SEK 12.6
(-1.18%)
SEK 12.6
(-1.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -27.26 Million | -24.97 Million | -20.33 Million | -17.42 Million | -16.94 Million | -18.99 Million |
| Net Income | -29.18 Million | -27.94 Million | -21.76 Million | -19.75 Million | -24.88 Million | -26.68 Million |
| Depreciation & Amortization | 2.45 Million | 2.45 Million | 1.54 Million | 2.56 Million | 5.6 Million | 8.05 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -529.86 Thousand | 510.67 Thousand | -111.12 Thousand | -238.98 Thousand | 2.33 Million | -366.99 Thousand |
| Other non-cash items | 4.22 Million | 4.39 Million | 2.88 Million | -1.00 | 5.48 Million | 16.48 Million |
| Investing Cash Flow | -1.15 Million | -389.49 Thousand | -1.3 Million | -3.12 Million | -1.8 Million | 177.71 Thousand |
| Investments in PPE | -1.15 Million | -389.49 Thousand | -1.3 Million | -3.12 Million | -1.78 Million | -18.8 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -9140.00 | - | - | - | -22.15 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | - | 196.51 Thousand |
| Other Investing Activities | 9140.00 | - | -1.3 Million | -2.99 Million | -22.15 Thousand | 196.51 Thousand |
| Financing Cash Flow | 33.2 Million | 65.2 Thousand | 35.07 Million | 32.53 Million | 21.78 Million | 18.71 Million |
| Debt repayment | - | - | -7.12 Million | -6.88 Million | -4.73 Million | -3 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 33.2 Million | 65.2 Thousand | 35.07 Million | 34.41 Million | 24.6 Million | 19.71 Million |
| Other Financing Activities | 33.2 Million | 65.2 Thousand | 7.12 Million | 5 Million | 1.91 Million | 2 Million |
| Accounts receivables | 574.13 Thousand | -1.64 Million | 796.14 Thousand | -822.03 Thousand | 826.83 Thousand | -593.72 Thousand |
| Accounts payables | -698.96 Thousand | 2.35 Million | -464.69 Thousand | -414.57 Thousand | 626.25 Thousand | -56.49 Thousand |
| Inventory | -405.03 Thousand | -193.4 Thousand | -442.58 Thousand | 997.63 Thousand | 678.06 Thousand | 283.22 Thousand |
| Other working capital | -698.96 Thousand | 2.45 Million | -464.69 Thousand | -414.57 Thousand | 206.46 Thousand | -650.21 Thousand |
| Cash at beginning of period | 3.67 Million | 28.97 Million | 15.54 Million | 3.55 Million | 522.51 Thousand | 628.85 Thousand |
| Cash at end of period | 8.45 Million | 3.67 Million | 28.97 Million | 15.54 Million | 3.55 Million | 522.51 Thousand |
| Capital Expenditure | -1.15 Million | -389.49 Thousand | -1.3 Million | -3.12 Million | -1.78 Million | -18.8 Thousand |
| Effect of forex changes on cash | - | -1.00 | - | - | - | - |
| Net cash flow / Change in cash | 4.77 Million | -25.3 Million | 13.43 Million | 11.98 Million | 3.03 Million | -106.33 Thousand |
| Free Cash Flow | -28.42 Million | -25.36 Million | -21.63 Million | -20.55 Million | -18.73 Million | -19.01 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.02 Million | -6.01 Million | -29.18 Million | -9.84 Million | -4.93 Million | -7.29 Million |
| Depreciation & Amortization | 554.73 Thousand | 554.73 Thousand | 2.45 Million | 612.76 Thousand | 613.31 Thousand | 613.85 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -530.68 Thousand | -443.59 Thousand | -529.86 Thousand | 1.72 Million | -636.34 Thousand | 358.08 Thousand |
| Other non-cash items | 1.64 Million | 1.55 Million | 4.22 Million | -1.00 | -1.00 | 869.62 Thousand |
| Investing Cash Flow | -1.86 Million | -779.65 Thousand | -1.15 Million | -488.01 Thousand | -347.79 Thousand | -313 Thousand |
| Investments in PPE | -1.86 Million | -779.65 Thousand | -1.15 Million | -513.47 Thousand | -331.47 Thousand | -313 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -9140.00 | 16.32 Thousand | -16.32 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.16 Million | -380.95 Thousand | 9140.00 | 9140.00 | -343.86 Thousand | -273.6 Thousand |
| Financing Cash Flow | -68.01 Thousand | 18.67 Million | 33.2 Million | - | - | 231 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -68.01 Thousand | - | - | - | - | - |
| Common Stock Issuance | -68.01 Thousand | 18.67 Million | 33.2 Million | - | - | 231 Thousand |
| Other Financing Activities | - | 18.67 Million | 33.2 Million | - | - | 231 Thousand |
| Accounts receivables | 118.33 Thousand | -140.83 Thousand | 574.13 Thousand | -799.84 Thousand | 359.56 Thousand | 642.1 Thousand |
| Accounts payables | -736.33 Thousand | -130.75 Thousand | -698.96 Thousand | 2.55 Million | -987.48 Thousand | -268.81 Thousand |
| Inventory | 87.32 Thousand | -172.01 Thousand | -405.03 Thousand | -28.85 Thousand | -8424.00 | -15.2 Thousand |
| Other working capital | -736.33 Thousand | -130.75 Thousand | -698.96 Thousand | 2.55 Million | 1.00 | -1.00 |
| Cash at beginning of period | 20.44 Million | 8.45 Million | 3.67 Million | 16.44 Million | 21.75 Million | 28.15 Million |
| Cash at end of period | 11.51 Million | 20.44 Million | 8.45 Million | 8.45 Million | 16.44 Million | 21.75 Million |
| Capital Expenditure | -1.86 Million | -779.65 Thousand | -1.15 Million | -513.47 Thousand | -331.47 Thousand | -313 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8.93 Million | 11.98 Million | 4.77 Million | -7.98 Million | -5.3 Million | -6.4 Million |
| Free Cash Flow | -8.86 Million | -6.68 Million | -28.42 Million | -8.01 Million | -5.29 Million | -6.63 Million |
COVTY
688378
OVTZ
HARVIA
3708
VASO